Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations

O Casar-Borota, HB Boldt, BE Engström… - The Journal of …, 2021 - academic.oup.com
Abstract Context Aggressive pituitary tumors (APTs) are characterized by unusually rapid
growth and lack of response to standard treatment. About 1% to 2% develop metastases …

The chromatin remodeler ATRX: role and mechanism in biology and cancer

Y Pang, X Chen, T Ji, M Cheng, R Wang, C Zhang… - Cancers, 2023 - mdpi.com
Simple Summary ATRX is one of the most frequently mutated tumor suppressor genes in
human cancers. ATRX protein is a chromatin remodeler and transcriptional regulator that is …

TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas

Y Miyake, J Adachi, T Suzuki, K Mishima, R Araki… - Journal of neuro …, 2019 - Springer
Purpose Alterations in the promoter of the telomerase reverse transcriptase (TERT) gene are
a major mechanism of upregulating telomerase, which plays a crucial role in tumor …

Pituitary adenoma in pediatric and adolescent populations

J Chen, RE Schmidt, S Dahiya - Journal of Neuropathology & …, 2019 - academic.oup.com
Pituitary adenomas are rare in children and adolescents and although mostly benign, they
can sometimes be challenging to manage due to their locally invasive nature. In this study …

In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation

A Nasirden, T Saito, Y Fukumura, K Hara, K Akaike… - Virchows Archiv, 2016 - Springer
The prognostic value of BRAF V600E and TERT promoter mutation in papillary thyroid
carcinoma (PTC) is controversial. We examined alterations in BRAF V600E and TERT …

ATRX, a guardian of chromatin

P Aguilera, AJ López-Contreras - Trends in Genetics, 2023 - cell.com
ATRX (alpha-thalassemia mental retardation X-linked) is one of the most frequently mutated
tumor suppressor genes in human cancers, especially in glioma, and recent findings …

Association of TERT Promoter Mutation 1,295,228 C>T With BRAF V600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer

X Shi, R Liu, S Qu, G Zhu, J Bishop, X Liu… - The Journal of …, 2015 - academic.oup.com
Context: The aggressive role of TERT promoter mutations has been well established in
differentiated thyroid cancer but has not been established in anaplastic thyroid cancer …

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

T Liu, TC Brown, CC Juhlin… - Endocrine-related …, 2014 - erc.bioscientifica.com
The telomerase reverse transcriptase gene (TERT) encodes the reverse transcriptase
component of the telomerase complex, which is essential for telomere stabilization and cell …

Mutant ATRX: uncovering a new therapeutic target for glioma

S Haase, MB Garcia-Fabiani, S Carney… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: ATRX is a chromatin remodeling protein whose main function is the deposition
of the histone variant H3. 3. ATRX mutations are widely distributed in glioma, and correlate …

Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

JM Pita, IF Figueiredo, MM Moura… - The Journal of …, 2014 - academic.oup.com
Background: Anaplastic thyroid carcinomas (ATCs) are among the most lethal malignancies,
for which there is no effective treatment. Objective: In the present study, we aimed to …